NCT06256627 2024-02-13
The Maintenance Treatment of "ITIVA" in AML Patients
Henan Cancer Hospital
Phase NA Recruiting
Clinical Trials
3 trialsNCT01517347 2016-10-24
Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation
Peking University People's Hospital
Phase NA Terminated
NCT00187096 2014-06-19
Natural Killer (NK) Cell Transplantation for AML
St. Jude Children's Research Hospital
Phase NA Completed